Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP
In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding
Univ. Of Pittsburg distances Itself From Fisher
Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths
A Transcript: what Fisher Knew, When Did He Know
NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









